IT

Ian Turner

Radiopharm Theranostics Limited | Non-Executive Director
Mr Turner, since August 2022, is also non-executive director at AtomVie Global Radiopharma Inc, a global contract development and manufacturing organization, launched by the Centre for ProbeDevelopment and Commercialisation (CPDC). Mr. Turner was a director of Coqui Pharmaceuticals from November 2014 to March 2019. Mr.Turner was Chief Executive Officer at Siemens Radiopharmaceuticals, which operated a global PET radio-pharmacy network, from 2010 to 2012. Prior to that, he was General Manager of ANSTO Radiopharmaceuticals, which was Australia's manufacturer of radioisotopes for the nuclear medicine sector. Since 2013, Mr. Turner is the CEO of the Turner Group LLC, a boutique management consulting firm that advises institutional investors on acquisition targets in the field of nuclear medicine, radiochemicals and radiopharmaceuticals He chairs risk committee.

Company and Role

Company
Title
Tenure
Since
RAD
Radiopharm Theranostics Limited
  • Non-Executive Director
3yrs, 10mthApr 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RAD
Radiopharm Theranostics Limited
16/12/242,530,5952,424,69718,988,350N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RAD
Radiopharm Theranostics Limited
16/12/24
Issued
12,040,404$0.027$325,090Issue of options
RAD
Radiopharm Theranostics Limited
18/10/24
Buy
333,864$0.028$9,348On-market trade
RAD
Radiopharm Theranostics Limited
13/09/24
Issued
2,250,000$0.040$90,000Placement
RAD
Radiopharm Theranostics Limited
13/09/24
Issued
1,500,000$0.040$60,000Placement
RAD
Radiopharm Theranostics Limited
13/09/24
Issued
1,875,000$0.030$56,250Placement